130 related articles for article (PubMed ID: 2209602)
1. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
Ravel S; Casellas P
Eur J Biochem; 1990 Sep; 192(2):469-73. PubMed ID: 2209602
[TBL] [Abstract][Full Text] [Related]
2. Internalization and intracellular fate of anti-CD5 monoclonal antibody and anti-CD5 ricin A-chain immunotoxin in human leukemic T cells.
Ravel S; Colombatti M; Casellas P
Blood; 1992 Mar; 79(6):1511-7. PubMed ID: 1372189
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.
van Oosterhout YV; Preijers FW; Wessels HM; de Witte T
Cancer Res; 1992 Nov; 52(21):5921-5. PubMed ID: 1394218
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.
Derocq JM; Casellas P; Laurent G; Ravel S; Vidal H; Jansen F
J Immunol; 1988 Oct; 141(8):2837-43. PubMed ID: 3262669
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of fresh leukemic cells to T101 ricin A-chain immunotoxin: a comparative study between Fab fragment and whole Ig conjugates.
Chiron M; Derocq JM; Kuhlein E; Roubinet F; Demur C; Grandjean H; Huguet F; Jaffrezou JP; Jansen F; Laurent G
Leuk Res; 1989; 13(6):491-9. PubMed ID: 2788783
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A and cyclosporin SDZ PSC 833 enhance anti-CD5 ricin A-chain immunotoxins in human leukemic T cells.
Jaffrézou JP; Sikic BI; Laurent G
Blood; 1994 Jan; 83(2):482-9. PubMed ID: 7506953
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
[TBL] [Abstract][Full Text] [Related]
9. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
10. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
11. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
13. Antigenic modulation by anti-CD5 immunotoxins.
Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA
J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441
[TBL] [Abstract][Full Text] [Related]
14. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells.
Wargalla UC; Reisfeld RA
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5146-50. PubMed ID: 2544891
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin.
Carrière D; Casellas P; Richer G; Gros P; Jansen FK
Exp Cell Res; 1985 Feb; 156(2):327-40. PubMed ID: 2857124
[TBL] [Abstract][Full Text] [Related]
16. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW
Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518
[TBL] [Abstract][Full Text] [Related]
17. Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.
Better M; Bernhard SL; Lei SP; Fishwild DM; Lane JA; Carroll SF; Horwitz AH
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):457-61. PubMed ID: 7678457
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow.
Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ
Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of cytotoxicity induced by immunotoxins. Enhancement by lysosomotropic amines and carboxylic ionophores.
Casellas P; Bourrie BJ; Gros P; Jansen FK
J Biol Chem; 1984 Aug; 259(15):9359-64. PubMed ID: 6746651
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
